News
All NewsBlogs
Media
All VideosCase-Based Roundtable SeriesEichenbaum AcornsExpert InterviewsEyeviewsInsightsMedical World NewsPodcastsRapid ReadoutsThe Retina TL;DRViewpoints
Conference
Conference CoverageConference Listing
Publications
Modern Retina Digital EditionSupplements And Featured Publications
More
Resources
Between the LinesCME/CEEYLEA 8mg for nAMD and DME TreatmentSponsored Resources
Partners

Subscribe

  • News
    • All News
    • Blogs
  • Media
    • Conference
      • Publications
        • Resources
          • Partners
          • Subscribe
          • AMD
            • Wet AMD
          • Biosimilar
          • Diabetic Macular Edema
            • Diabetic Eye Awareness
          • Diabetic Retinopathy
          • Geographic Atrophy
          • Imaging
          • Inherited Retinal Diseases
          • Ophthalmology
            • Europe
          • RVO
          • Retina Technology
          • Retinal Surgery
          • Uveitis
          Spotlight -
          Geographic Atrophy
          Advertisement

          Raj N. Patel, MD

          Advertisement

          Articles by Raj N. Patel, MD

          Improving patient experience with intravitreal injections

          ByRaj N. Patel, MD
          August 15th 2025

          The role of anesthetics in streamlining efficiency and elevating patient care.

          Advertisement

          Latest Updated Articles

          • Improving patient experience with intravitreal injections
            Improving patient experience with intravitreal injections

            Published: August 15th 2025 | Updated:



          Advertisement
          Advertisement

          Trending on Modern Retina

          1

          Navigating the maze: Establishing novel endpoints for IRD trials

          2

          Eichenbaum Acorns: A leadership conversation with Rishi P. Singh, MD, FASRS, on advancing CME

          3

          Two experts present on acute optic neuritis and the ACUITY trial during EURETINA 2025

          4

          Positive pediatric data emerge from the OPGx-LCA5 phase 1/2 trial of Leber congenital amaurosis type 5

          5

          Anniversary of the spectral OCT prototype: 25 years young and growing

          • About
          • Advertise
          • Editorial
          • Contact Us
          • Terms and Conditions
          • Privacy
          • Do Not Sell My Personal Information
          Contact Info

          259 Prospect Plains Rd, Bldg H
          Monroe, NJ 08831

          609-716-7777

          Brand Logo

          © 2025 MJH Life Sciences®

          All rights reserved.

          Home
          About Us
          News
          Contact Us